CAMP4 THERAPEUTICS CORPORATION CAMP
3.80 USD -0.03 (-0.78%)
Nov 4, 2026, 2:26 PM EST
3.77 Day range 4.01
2.90 52-week range 7.75
- YTD
- -38.01%
- 1 year
- +0.80%
Financial health
Altman Z-Score
-5.30 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.3×
FY 2023 5y median -2.3× FY 2025
P/S 53.2×
FY 2023 5y median 156× FY 2025
P/B 3.9×
FY 2023 5y median 1.6× FY 2025
P/FCF -6.2×
FY 2023 5y median -2.9× FY 2025
EV/EBITDA -1.6×
FY 2023 5y median -1.6× FY 2025
EV/Sales 22.5×
FY 2023 5y median 71.2× FY 2025
FCF Yield -16.0%
FY 2023 5y median -34.5% FY 2025
Profitability
Gross Margin 53.1%
FY 2023 5y median 100.0% FY 2025
Operating Margin -1488.3%
FY 2023 5y median -8142.3% FY 2025
Net Margin -2298.5%
FY 2023 5y median -7943.4% FY 2025
ROE -168.5%
FY 2023 5y median -82.0% FY 2025
ROIC -50.8%
FY 2023 5y median -73.9% FY 2025
ROA -68.2%
FY 2023 5y median -68.2% FY 2025
Growth (YoY)
Revenue 436.5%
FY 2023 FY 2025
Operating Income 1.9%
FY 2023 FY 2025
EPS (diluted) 0.4%
FY 2023 FY 2025
Free Cash Flow 35.2%
FY 2023 FY 2025
Financial Health
Current Ratio 7.4×
FY 2023 5y median 6.9× FY 2025
Quick Ratio 7.4×
FY 2023 5y median 6.9× FY 2025
Debt / Equity 0.0×
FY 2023 5y median 0.0× FY 2025
Net Debt / EBITDA 2.1×
FY 2023 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2023 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31